We are live on ! Find out more
CA

Callahan Advisors Portfolio holdings

AUM $1.33B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
-1.94%
1 Year Est. Return
+29.71%
3 Year Est. Return
+87.75%
5 Year Est. Return
+121.89%
10 Year Est. Return
+408.77%
AUM
$796M
AUM Growth
-$26.8M
Cap. Flow
-$2.58M
Cap. Flow %
-0.32%
Top 10 Hldgs %
33.24%
Holding
141
New
8
Increased
58
Reduced
61
Closed
1

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$4.93M
2
LLY icon
Eli Lilly
LLY
+$3.48M
3
BKNG icon
Booking.com
BKNG
+$1.75M
4
DHI icon
D.R. Horton
DHI
+$1.73M
5
DY icon
Dycom Industries
DY
+$1.43M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.93M
2
DIS icon
Walt Disney
DIS
+$2.91M
3
T icon
AT&T
T
+$2.64M
4
DLTR icon
Dollar Tree
DLTR
+$2.46M
5
CVS icon
CVS Health
CVS
+$2.29M

Sector Composition

Rank Sector Weight
1 Technology 17.54%
2 Healthcare 14.51%
3 Financials 12.75%
4 Consumer Discretionary 10.61%
5 Energy 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
META icon
1
Meta Platforms (Facebook)
META
$1.5T
$37.3M 4.69%
124,374
+2,151
+2% +$648K
MSFT icon
2
Microsoft
MSFT
$3.62T
$37.1M 4.66%
117,409
-977
-0.8% -$323K
GOOG icon
3
Alphabet (Google) Class C
GOOG
$4.56T
$32.9M 4.13%
249,174
-2,870
-1% -$373K
AAPL icon
4
Apple
AAPL
$4.46T
$30.5M 3.83%
178,107
-7,307
-4% -$1.34M
AMZN icon
5
Amazon
AMZN
$3.06T
$24.8M 3.12%
195,119
+7,359
+4% +$986K
UNH icon
6
UnitedHealth
UNH
$377B
$22.3M 2.81%
44,307
+19
+0% +$9.35K
BRK.B icon
7
Berkshire Hathaway Class B
BRK.B
$1.11T
$21.9M 2.75%
62,592
+33
+0.1% +$11.7K
JPM icon
8
JPMorgan Chase
JPM
$937B
$19.9M 2.51%
137,560
+362
+0.3% +$54.3K
FDX icon
9
FedEx
FDX
$73.2B
$19.6M 2.46%
73,874
-558
-0.7% -$145K
JNJ icon
10
Johnson & Johnson
JNJ
$613B
$18.3M 2.3%
117,481
-2,614
-2% -$431K
CB icon
11
Chubb
CB
$134B
$18.1M 2.28%
87,155
+2,434
+3% +$492K
CVX icon
12
Chevron
CVX
$385B
$17.9M 2.25%
106,008
-2,527
-2% -$408K
CAT icon
13
Caterpillar
CAT
$382B
$17.8M 2.24%
65,283
+1,126
+2% +$305K
XOM icon
14
ExxonMobil
XOM
$643B
$16.5M 2.08%
140,699
-3,070
-2% -$337K
LOW icon
15
Lowe's Companies
LOW
$119B
$16.5M 2.07%
79,322
+5,428
+7% +$1.22M
MCD icon
16
McDonald's
MCD
$188B
$15.4M 1.93%
58,468
-930
-2% -$265K
SYK icon
17
Stryker
SYK
$131B
$14.8M 1.85%
54,037
-1,254
-2% -$360K
PEP icon
18
PepsiCo
PEP
$191B
$14.6M 1.84%
86,308
-458
-0.5% -$83.2K
BN icon
19
Brookfield
BN
$107B
$14.5M 1.83%
697,715
+18,650
+3% +$420K
AMAT icon
20
Applied Materials
AMAT
$411B
$14M 1.75%
100,800
-5,252
-5% -$753K
PG icon
21
Procter & Gamble
PG
$338B
$13.9M 1.75%
95,482
-1,883
-2% -$288K
EQT icon
22
EQT Corp
EQT
$33.5B
$13.7M 1.72%
337,123
+11,961
+4% +$495K
CSCO icon
23
Cisco
CSCO
$457B
$12.4M 1.56%
231,353
-2,987
-1% -$161K
EOG icon
24
EOG Resources
EOG
$77.6B
$11.3M 1.42%
89,225
-305
-0.3% -$38.8K
WMT icon
25
Walmart Inc
WMT
$881B
$11.2M 1.4%
209,724
+696
+0.3% +$37K

Similar funds

Callahan Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Callahan Advisors held 141 positions worth $796M, down 3.3% from $823M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Callahan Advisors's Q3 2023 filing shows 8 new, 58 increased, 61 reduced and 1 closed positions. Its largest new stake was Mastercard: 12,272 shares worth $4.86M. The largest sale was Bristol-Myers Squibb, an estimated $2.93M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

  • Callahan Advisors's largest Q3 2023 buy was Mastercard: 12,272 shares worth $4.86M.
  • Callahan Advisors added most to Eli Lilly in Q3 2023, an estimated $3.48M increase.
  • Callahan Advisors's biggest Q3 2023 reduction was Bristol-Myers Squibb, cutting an estimated $2.93M.
  • Callahan Advisors fully exited Schwab US TIPS ETF in Q3 2023, selling an estimated $322K.
  • Callahan Advisors's ten largest holdings make up 33% of its $796M portfolio in Q3 2023.
  • Callahan Advisors opened 8 new positions and closed 1 in Q3 2023.
  • Callahan Advisors's portfolio value fell 3.3% quarter-over-quarter to $796M.

Based on Callahan Advisors's 13F filing for Q3 2023, filed 23 Oct 2023.